On December 5, 2023, FSD Pharma Inc closed the transaction. The transaction included participation from new investor Xorax Family Trust for 12 Class A shares for gross proceeds of CAD 22.80.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 CAD | -7.22% | -4.26% | -62.50% |
1st Jan change | Capi. | |
---|---|---|
-62.50% | 14.25M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- HUGE Stock
- News FSD Pharma Inc.
- FSD Pharma Inc. announced that it has received CAD 0.000046 million in funding